Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 217646
Company: ENCUBE

Products on ANDA 217646

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 217646

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/09/2025	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 217646

DICLOFENAC SODIUM

SOLUTION;TOPICAL; 2%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	No	AB	212506	ALEMBIC
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	No	AB	208198	AMNEAL
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	No	AB	207714	APOTEX
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	No	AB	213040	AUROLIFE PHARMA LLC
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	No	AB	217646	ENCUBE
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	No	AB	208021	LUPIN PHARMS
DICLOFENAC SODIUM	DICLOFENAC SODIUM	2%	SOLUTION;TOPICAL	Prescription	No	AB	208098	SUN PHARMA CANADA